Episurf Medical AB

Equities

EPIS B

SE0003491562

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Stockholm Other stock markets 16:29:55 28/05/2024 BST			5-day change	1st Jan Change
0.277 ^SEK	-9.18%		-28.52%	-72.02%

04-24	Episurf Medical Announces Distributor Agreement with Depuy-Synthes	CI
04-24	Episurf Medical AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Episurf Medical AB Promotes Michael Näsström as Head of Quality and Regulatory Affairs, Effective February 1, 2021

January 29, 2021 at 08:50 am

Episurf Medical AB announces that effective as of February 1st 2021, Michael Näsström has been appointed as Head of Quality and Regulatory Affairs and will take part in the Management Group of Episurf Medical. Michael is currently serving as Quality Manager in the company.

Latest news about Episurf Medical AB

Episurf Medical Announces Distributor Agreement with Depuy-Synthes	04-24	CI
Episurf Medical AB Reports Earnings Results for the First Quarter Ended March 31, 2024	04-24	CI
Episurf Medical Plans SEK120 Million Rights Issue	04-22	MT
Episurf Medical AB Elects Jess Lonner as New Member of the Board of Directors	04-09	CI
Episurf Medical AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	02-09	CI
Sweden's Episurf Medical Secures New Patents in Asia, South Africa	11-28	MT
Episurf Medical AB Receives Four Additional Patent Approval Notification	11-28	CI
Episurf Medical AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	27/10/23	CI
Episurf Medical Announces 510(k) Submission for Big Toe Implant	20/10/23	CI
Episurf Members Announces Nomination Committee for Episurf Medical's Annual General Meeting in 2024	17/10/23	CI
Episurf Medical Announces Early Clinical Results from Episealer Talus Study Presented at Scientific Congress	28/09/23	CI
Episurf Medical Announces Prospective Episealer Talus Clinical Study	13/09/23	CI
Episurf Medical's New Knee Joint Implant System Scheduled For Surgery Use in US	23/08/23	MT
Episurf Medical AB Announces First Commercial Case in the US Has Been Scheduled for Surgery	23/08/23	CI
Episurf Announces Results from the Use of Episealer Accepted for Publication in Scientific Journal	31/07/23	CI
Episurf Medical AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/07/23	CI
Episurf Medical Wins Hospital Value Analysis Committee's Approval for Implant System	07/07/23	MT
Episurf Medical AB Reports Earnings Results for the First Quarter Ended March 31, 2023	28/04/23	CI
Episurf Medical Builds US Distributor Network for Episealer Patellofemoral System	11/04/23	MT
Episurf Medical Receives Another Granted Patent in India	02/03/23	CI
Episurf Medical Receives Another Notice of Allowance from the United States Patent and Trademark Office	01/03/23	CI
Episurf Medical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	17/02/23	CI
Episurf Medical AB Reports Earnings Results for the Full Year Ended December 31, 2022	17/02/23	CI
Episurf Medical AB Announces Dennis Stripe Not Stand for Re-Election as Chairman of the Board of Directors	13/02/23	CI
Episurf Medical AB Receives Notice of Allowance from the United States Patent and Trademark Office	02/02/23	CI

Chart Episurf Medical AB

Duration

Period

More charts

Company Profile

Episurf Medical AB is a Sweden-based medical technology company. It is engaged in the development, manufacture and marketing of implants and surgical drilling templates used in the treatment of local cartilage damage in knee joints. The Companyâs product portfolio includes the Episealer, and individually customized implant used as a cartilage replacement for early-stage patients; and Epiguide, a drill guide designed to attach to the kneeâs surface, as well as related surgical tools. The personalization of implants and instruments is based on magnetic resonance imaging (MRI) and enables less invasive treatment. The process of ordering and creation of patient-specific implants and surgical instruments is covered by software suite, microiFidelity, comprising microiClinic, microiDesign and microiManufacture. The main shareholder of the Company is Serendipity Ixora Fund AB.

Sector

Medical Equipment, Supplies & Distribution

Calendar

12/07/2024 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Episurf Medical AB

Trading Rating

Investor Rating

ESG Refinitiv

D+

More Ratings

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Medical Devices & Implants

	1st Jan change	Capi.
EPISURF MEDICAL AB	-72.02%	7.69M
STRYKER CORPORATION	+13.31%	128B
SMITH & NEPHEW PLC	-9.13%	10.9B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	-2.59%	8.69B
GLAUKOS CORPORATION	+37.50%	5.48B
INSPIRE MEDICAL SYSTEMS, INC.	-22.36%	4.72B
ENOVIS CORPORATION	-11.25%	2.76B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-14.85%	2.05B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-13.29%	1.93B
DOUBLE MEDICAL TECHNOLOGY INC.	-28.75%	1.67B

Medical Devices & Implants